MUC16 and central nervous system cancer: Few mutations were identified in MUC16 in primary GBM samples, but a 15 percent mutation frequency was observed in recurrent GBM (Figure 2A–2B) in the CGGA (Chinese Glioma Genome Atlas) GBM database, validating our results.